Safe Harbor Fiduciary’s GSK GSK Stock Holding History

Safe Harbor Fiduciary’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100	Closed	-$4.9K	–	103
2025 Q4	$4.9K	Buy	+100	New	+$4.66K	﹤0.01%	180

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Safe Harbor Fiduciary's GSK Position: Q1 2026 in Review

Safe Harbor Fiduciary sold out of GSK (GSK) in Q1 2026, closing a stake of 100 shares — an estimated $4.9K sold.

Safe Harbor Fiduciary first reported a position in GSK in Q4 2025 and held it in 1 quarter. The position peaked at $4.9K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Safe Harbor Fiduciary reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Safe Harbor Fiduciary sold 100 GSK shares in Q1 2026, an estimated $4.9K.
Safe Harbor Fiduciary first reported a position in GSK in Q4 2025 and held it in 1 quarter.
Safe Harbor Fiduciary's GSK position peaked at $4.9K in Q4 2025.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Safe Harbor Fiduciary's 13F filing for Q1 2026, filed 15 May 2026.